Skip to content
Abierto
Menu

Award notice

INFLUENZA VIRUS VAC

SPE2DP23R00040001

Defense Logistics Agency, DLA Troop Support. Biological Product (except Diagnostic) Manufacturing.

View on SAM.govMarkdown

Awarded

Glaxosmithkline, LLC

$2,327,325.00 on the award notice, March 13, 2024, contract SPE2DP24D0005

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Seqirus USA Inc.
UEI
N6U7P2B9VHS5
CAGE
530P3
Vendor location
Summit, NJ
Contract
SPE2DP24D0004
Obligated
$0.00, potential $36,120,113
Actions
2 between March 13, 2024 and May 21, 2024
Competition
Full and Open Competition, 4 offers received
Set-aside reported
No Set Aside Used.
Described as
4610108657!influenza Virus Vac
Match
award number SPE2DP24D0004 equals the contract number; same awarding office SPE2DP (high confidence)
Record
USAspending award page
Recipient
Glaxosmithkline, LLC
UEI
FRHTPHMZMX47
CAGE
667E9
Vendor location
Durham, NC
Contract
SPE2DP24D0005
Obligated
$0.00, potential $2,327,325
Actions
2 between March 13, 2024 and May 21, 2024
Competition
Full and Open Competition, 4 offers received
Set-aside reported
No Set Aside Used.
Described as
4610108702!influenza Virus Vac
Match
award number SPE2DP24D0005 equals the contract number; same awarding office SPE2DP (high confidence)
Record
USAspending award page
Recipient
Sanofi Vaccines US Inc.
UEI
NCXBGGQ8YTU9
CAGE
7V915
Vendor location
Swiftwater, PA
Contract
SPE2DP24D0006
Obligated
$0.00, potential $4,023,281
Actions
2 between March 13, 2024 and May 21, 2024
Competition
Full and Open Competition, 4 offers received
Set-aside reported
No Set Aside Used.
Described as
4610108703!influenza Virus Vac
Match
award number SPE2DP24D0006 equals the contract number; same awarding office SPE2DP (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. March 13, 2024

    Award notice

    Awarded to Sanofi Pasteur Inc. for $4,023,281. SAM.gov, notice 1a006768511f4406b95010f3815dd49e

  2. March 13, 2024

    Award notice

    Awarded to Seqirus USA Inc. for $36,120,113. SAM.gov, notice 290324457a524fb5be35213c1dc7a902

  3. March 13, 2024

    Award notice

    Awarded to Glaxosmithkline, LLC for $2,327,325. SAM.gov, notice cf24eab1ccf94e50a7891afe39c727a2

Points of contact

Also open from this buyer